Zimmer Biomet Holdings Stock Price and Value Analysis

Should you buy Zimmer Biomet Holdings stock? (NYSE:ZBH). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Zimmer Biomet Holdings to reach your target.

Target type

ZBH Free Cash Flow Trend

Free Cash Flow trendline for ZBH
Free Cash Flow trendline for Zimmer Biomet Holdings
CSV

Based on historical returns, we believe that Zimmer Biomet Holdings can grow its free cash at a rate of about 2%. That's positive!

AdvantagesDisadvantages
None.
  • This company has wild ups and downs.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company is making money at a modest rate.

Inside the ZBH Numbers

ZBH Price
(Zimmer Biomet Holdings stock price per share)
$95.36
[?] ZBH Fair Price
(based on intrinsic value)
$59.77
[?] ZBH Safety Price (based on a variable margin of safety) $35.86
[?] PE Ratio versus Sector 14% higher than other Healthcare stocks
[?] PE Ratio versus Industry 3% lower than other Medical Instruments & Supplies stocks
[?] Free Cash Flow Jitter 54%
[?] Dividend Yield 1% (tax impact)
Shares Shorted 8,788,234

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 8,788,234 shares shorted. With 190,125,421 shares available for purchase and an average trading volume over the past 10 trading days of 2,078,510, it would take at least 4.228 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Zimmer Biomet Holdings Stock on Sale?

We believe that Zimmer Biomet Holdings may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Zimmer Biomet Holdings looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Advertisement supports free stock analysis content.

Should You Buy ZBH Stock?

Does Zimmer Biomet Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: ZBH

This example shows how we apply the Trendshare checklist to ZBH: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 95.36
    • Market cap: $18B
    • EPS: 4.12
  2. Step 2 — Valuation checks

    • P/E: 23.146
    • FCF yield: —
    • Date checked: Sep 18, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.

Most Popular Articles